Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ran-ran Ding, Jian-ling Yuan, Ya-nan Jia, Xiao-min Liao, Si-si Wang, Zhong-ming Shao, Mu-yin Feng, Wei Jie & Zhi-hua Shen. (2019) Epstein-Barr virus-encoded LMP1 regulated Pim1 kinase expression promotes nasopharyngeal carcinoma cells proliferation. OncoTargets and Therapy 12, pages 1137-1146.
Read now
Read now
Bassem H. Naguib, Hala B. El-Nassan & Tamer M. Abdelghany. (2017) Synthesis of new pyridothienopyrimidinone derivatives as Pim-1 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 32:1, pages 457-467.
Read now
Read now
Bassem H. Naguib & Hala B. El-Nassan. (2016) Synthesis of new thieno[2,3-b]pyridine derivatives as pim-1 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 31:6, pages 1718-1725.
Read now
Read now
Elodie Bohers, Sylvain Mareschal, Philippe Bertrand, Pierre Julien Viailly, Sydney Dubois, Catherine Maingonnat, Philippe Ruminy, Hervé Tilly & Fabrice Jardin. (2015) Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine era. Leukemia & Lymphoma 56:5, pages 1213-1222.
Read now
Read now
Articles from other publishers (26)
Kun Li, Yuanbo Xu, Jun Sun, Wei Zhang & Peizhi Ma. (2023) Design, Synthesis and Biological Evaluation of Novel Quinoline Derivatives as Potential
Anti-Proliferative Agents Against PC-3 and KG-1 Cells. Anti-Cancer Agents in Medicinal Chemistry 23:5, pages 599-611.
Crossref
Crossref
Vinayak Walhekar, Chandrakant Bagul, Dileep Kumar, Amol Muthal, Garlapati Achaiah & Ravindra Kulkarni. (2022) Topical advances in PIM kinases and their inhibitors: Medicinal chemistry perspectives. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:3, pages 188725.
Crossref
Crossref
Lizhao Hu, Yuyao Yang, Shuangjia Zheng, Jun Xu, Ting Ran & Hongming Chen. (2021) Kinase Inhibitor Scaffold Hopping with Deep Learning Approaches. Journal of Chemical Information and Modeling 61:10, pages 4900-4912.
Crossref
Crossref
Alaa Shafie, Shama Khan, Sagar Batra, Farah Anjum, Taj Mohammad, Shoaib Alam, Dharmendra Kumar Yadav, Asimul Islam & Md. Imtaiyaz Hassan. (2021) Investigating single amino acid substitutions in PIM1 kinase: A structural genomics approach. PLOS ONE 16:10, pages e0258929.
Crossref
Crossref
Farah AnjumTaj Mohammad, Abdulraheem Ali AlmalkiOmar AkhtarBekhzod AbdullaevMd. Imtaiyaz Hassan. (2021) Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery: Computational Identification of Potent Inhibitors of PIM1 Kinase. OMICS: A Journal of Integrative Biology 25:9, pages 580-590.
Crossref
Crossref
Amel M. Farrag, Mona H. Ibrahim, Ahmed B.M. Mehany & Magda M.F. Ismail. (2020) New cyanopyridine-based scaffold as PIM-1 inhibitors and apoptotic inducers: Synthesis and SARs study. Bioorganic Chemistry 105, pages 104378.
Crossref
Crossref
Soraya Alnabulsi & Enas A. Al-Hurani. (2020) Pim kinase inhibitors in cancer: medicinal chemistry insights into their activity and selectivity. Drug Discovery Today 25:11, pages 2062-2069.
Crossref
Crossref
Camilo E. Quevedo, Carole J.R. Bataille, Simon Byrne, Matthew Durbin, Jon Elkins, Abigail Guillermo, Alan M. Jones, Stefan Knapp, Anna Nadali, Roderick G. Walker, Isabel V.L. Wilkinson, Graham M. Wynne, Stephen G. Davies & Angela J. Russell. (2020) Aminothiazolones as potent, selective and cell active inhibitors of the PIM kinase family. Bioorganic & Medicinal Chemistry 28:22, pages 115724.
Crossref
Crossref
Xinyi Zhang, Yun Zou, Yuqi Liu, Yumeng Cao, Jiali Zhu, Jianhai Zhang, Xia Chen, Rui Zhang & Jinbao Li. (2020) Inhibition of PIM1 kinase attenuates bleomycin-induced pulmonary fibrosis in mice by modulating the ZEB1/E-cadherin pathway in alveolar epithelial cells. Molecular Immunology 125, pages 15-22.
Crossref
Crossref
Nagesh Kishan Panchal & E.P. Sabina. (2020) A serine/threonine protein PIM kinase as a biomarker of cancer and a target for anti-tumor therapy. Life Sciences 255, pages 117866.
Crossref
Crossref
Hui-Ling Wang, Kristin L. Andrews, Shon K. Booker, Jude Canon, Victor J. Cee, Frank ChavezJr.Jr., Yuping Chen, Heather Eastwood, Nadia Guerrero, Brad Herberich, Dean Hickman, Brian A. Lanman, Jimmy LaszloIIIIII, Matthew R. Lee, J. Russell Lipford, Bethany Mattson, Christopher Mohr, Yen Nguyen, Mark H. Norman, Liping H. Pettus, David Powers, Anthony B. Reed, Karen Rex, Christine Sastri, Nuria Tamayo, Paul Wang, Jeffrey T. Winston, Bin Wu, Qiong Wu, Tian Wu, Ryan P. Wurz, Yang Xu, Yihong Zhou & Andrew S. Tasker. (2019)
Discovery of (
R
)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4-
b
]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3
H
)-one, a Potent and Selective Pim-1/2 Kinase Inhibitor for Hematological Malignancies
. Journal of Medicinal Chemistry 62:3, pages 1523-1540.
Crossref
Crossref
Holly Koblish, Yun-long Li, Niu Shin, Leslie Hall, Qian Wang, Kathy Wang, Maryanne Covington, Cindy Marando, Kevin Bowman, Jason Boer, Krista Burke, Richard Wynn, Alex Margulis, Gary W. Reuther, Que T. Lambert, Valerie Dostalik Roman, Ke Zhang, Hao Feng, Chu-Biao Xue, Sharon Diamond, Greg Hollis, Swamy Yeleswaram, Wenqing Yao, Reid Huber, Kris Vaddi & Peggy Scherle. (2018) Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies. PLOS ONE 13:6, pages e0199108.
Crossref
Crossref
Niina M. Santio & Päivi J. Koskinen. (2017) PIM kinases: From survival factors to regulators of cell motility. The International Journal of Biochemistry & Cell Biology 93, pages 74-85.
Crossref
Crossref
Po-Shuan Huang, Yang-Hsiang Lin, Hsiang-Cheng Chi, Pei-Yu Chen, Ya-Hui Huang, Chau-Ting Yeh, Chia-Siu Wang & Kwang-Huei Lin. (2017) Thyroid hormone inhibits growth of hepatoma cells through induction of miR-214. Scientific Reports 7:1.
Crossref
Crossref
Xiaojing Wang, Aleksandr Kolesnikov, Suzanne Tay, Grace Chan, Qi Chao, Steven Do, Jason Drummond, Allen J. Ebens, Ning Liu, Justin Ly, Eric Harstad, Huiyong Hu, John Moffat, Veerendra Munugalavadla, Jeremy Murray, Dionysos Slaga, Vickie Tsui, Matthew Volgraf, Heidi Wallweber & Jae H. Chang. (2017) Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized Bioavailability. Journal of Medicinal Chemistry 60:10, pages 4458-4473.
Crossref
Crossref
Hirofumi Nakano, Tsukasa Hasegawa, Hirotatsu Kojima, Takayoshi Okabe & Tetsuo Nagano. (2017) Design and Synthesis of Potent and Selective PIM Kinase Inhibitors by Targeting Unique Structure of ATP-Binding Pocket. ACS Medicinal Chemistry Letters 8:5, pages 504-509.
Crossref
Crossref
Shuai Mou, Guangbin Wang, Ding Ding, Dongdong Yu, Yi Pei, Songling Teng & Qin Fu. (2016) Expression and function of PIM kinases in osteosarcoma. International Journal of Oncology 49:5, pages 2116-2126.
Crossref
Crossref
Ryan P. Wurz, Christine Sastri, Derin C. D’Amico, Brad Herberich, Claire L.M. Jackson, Liping H. Pettus, Andrew S. Tasker, Bin Wu, Nadia Guerrero, J. Russell Lipford, Jeffrey T. Winston, Yajing Yang, Paul Wang, Yen Nguyen, Kristin L. Andrews, Xin Huang, Matthew R. Lee, Christopher Mohr, J.D. Zhang, Darren L. Reid, Yang Xu, Yihong Zhou & Hui-Ling Wang. (2016) Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 26:22, pages 5580-5590.
Crossref
Crossref
Makaram M. Said, Azza T. Taher, Hala B. El-Nassan & Eman A. El-Khouly. (2016) Synthesis of novel S-acyl and S-alkylpyrimidinone derivatives as potential cytotoxic agents. Research on Chemical Intermediates 42:8, pages 6643-6662.
Crossref
Crossref
Liping H. Pettus, Kristin L. Andrews, Shon K. Booker, Jie Chen, Victor J. Cee, Frank ChavezJr.Jr., Yuping Chen, Heather Eastwood, Nadia Guerrero, Bradley Herberich, Dean Hickman, Brian A. Lanman, Jimmy LaszloIIIIII, Matthew R. Lee, J. Russell Lipford, Bethany Mattson, Christopher Mohr, Yen Nguyen, Mark H. Norman, David Powers, Anthony B. Reed, Karen Rex, Christine Sastri, Nuria Tamayo, Paul Wang, Jeffrey T. Winston, Bin Wu, Tian Wu, Ryan P. Wurz, Yang Xu, Yihong Zhou, Andrew S. Tasker & Hui-Ling Wang. (2016) Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors. Journal of Medicinal Chemistry 59:13, pages 6407-6430.
Crossref
Crossref
Yin-Bo Fan, Kun Li, Min Huang, Yu Cao, Ying Li, Shu-Yu Jin, Wen-Bing Liu, Jia-Chen Wen, Dan Liu & Lin-Xiang Zhao. (2016) Design and synthesis of substituted pyrido[3,2-d]-1,2,3-triazines as potential Pim-1 inhibitors. Bioorganic & Medicinal Chemistry Letters 26:4, pages 1224-1228.
Crossref
Crossref
YINGQIU XIE & SAMAT BAYAKHMETOV. (2016) PIM1 kinase as a promise of targeted therapy in prostate cancer stem cells. Molecular and Clinical Oncology 4:1, pages 13-17.
Crossref
Crossref
Niina M. Santio, Sini K. Eerola, Ilkka Paatero, Jari Yli-Kauhaluoma, Fabrice Anizon, Pascale Moreau, Johanna Tuomela, Pirkko Härkönen & Päivi J. Koskinen. (2015) Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts. PLOS ONE 10:6, pages e0130340.
Crossref
Crossref
Ryan P. Wurz, Liping H. Pettus, Claire Jackson, Bin Wu, Hui-Ling Wang, Brad Herberich, Victor Cee, Brian A. Lanman, Anthony B. Reed, Frank ChavezJr.Jr., Thomas Nixey, Jimmy LaszloIIIIII, Paul Wang, Yen Nguyen, Christine Sastri, Nadia Guerrero, Jeff Winston, J. Russell Lipford, Matthew R. Lee, Kristin L. Andrews, Christopher Mohr, Yang Xu, Yihong Zhou, Darren L. Reid & Andrew S. Tasker. (2015) The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 25:4, pages 847-855.
Crossref
Crossref
Bich Thuy Le, Malika Kumarasiri, Julian RJ Adams, Mingfeng Yu, Robert Milne, Matthew J Sykes & Shudong Wang. (2015) Targeting Pim kinases for cancer treatment: opportunities and challenges. Future Medicinal Chemistry 7:1, pages 35-53.
Crossref
Crossref
Cristina Girardi, Daniele Ottaviani, Lorenzo A. Pinna & Maria Ruzzene. (2015) Different Persistence of the Cellular Effects Promoted by Protein Kinase CK2 Inhibitors CX-4945 and TDB. BioMed Research International 2015, pages 1-9.
Crossref
Crossref